FMR LLC

Position in GILD — Gilead Sciences, Inc.

CIK 315066 BOSTON, MA

Back to GILD Full portfolio

Position in GILD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,021,579,632

+$1,972,353,034 QoQ

Shares Held

71,906,290

+9.6% QoQ

Ownership

5.79%

of shares outstanding

% of Portfolio

0.57%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 88.37521446315753.ToString("F0")% Shared 0.ToString("F0")% None 11.624785536842465.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

FMR LLC holds $65,159,031,340 across 17 Drug Manufacturers - General names. GILD ranks #2 (15.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	26,341,031	$24,227,690,080
2	GILD	Gilead Sciences, Inc. This page	71,906,290	$10,021,579,632
3	JNJ	Johnson & Johnson	24,771,828	$6,055,225,633
4	AZN	Astrazeneca PLC	29,601,724	$5,838,052,004
5	MRK	Merck & Co., Inc.	44,516,010	$5,354,830,840
6	ABBV	AbbVie Inc.	21,762,703	$4,733,170,273
7	GSK	GSK plc	67,661,646	$3,734,246,242
8	BIIB	Biogen Inc.	12,807,541	$2,348,006,489

All Filings in GILD

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,021,579,632	71,906,290	+9.6%	Shares	Defined	2026-05-15
2025-12-31	$8,049,226,598	65,579,490	+8.7%	Shares	Defined	2026-02-17
2025-09-30	$6,695,106,969	60,316,279	+0.6%	Shares	Defined	2025-11-13
2025-06-30	$6,647,252,644	59,955,377	+2.4%	Shares	Defined	2025-08-14
2025-03-31	$6,559,725,443	58,542,842	+45.2%	Shares	Defined	2025-05-12
2024-12-31	$3,724,305,930	40,319,432	+21.6%	Shares	Defined	2025-02-13
2024-09-30	$2,780,328,822	33,162,319	+79.4%	Shares	Defined	2024-11-13
2024-06-30	$1,268,060,856	18,482,158	+5.1%	Shares	Defined	2024-08-13
2024-03-31	$1,288,359,233	17,588,522	+2.9%	Shares	Defined	2024-05-13
2023-12-31	$1,385,080,461	17,097,648	-11.0%	Shares	Defined	2024-02-13
2023-09-30	$1,438,972,322	19,201,659	-4.3%	Shares	Defined	2023-11-13
2023-06-30	$1,546,888,460	20,071,214	-4.0%	Shares	Defined	2023-08-11
2023-03-31	$1,734,826,530	20,909,082	+27.2%	Shares	Defined	2023-08-11
2022-12-31	$1,411,279,821	16,438,903	+459.1%	Shares	Defined	2023-02-13
2022-09-30	$181,399,442	2,940,500	+0.0%	Shares	Defined	2022-11-10
2022-06-30	$181,689,998	2,939,492	-53.4%	Shares	Defined	2022-08-12
2022-03-31	$375,311,177	6,313,056	-19.3%	Shares	Defined	2022-05-13
2021-12-31	$567,995,788	7,822,556	+23.8%	Shares	Defined	2022-02-14
2021-09-30	$441,330,529	6,318,261	+80.1%	Shares	Defined	2022-02-14
2021-06-30	$241,633,663	3,509,057	+36.7%	Shares	Defined	2021-08-13
2021-03-31	$165,899,392	2,566,910	-31.7%	Shares	Defined	2021-05-14
2020-12-31	$218,908,394	3,757,439	-51.3%	Shares	Defined	2021-02-08
2020-09-30	$487,209,116	7,710,225	-38.8%	Shares	Defined	2020-11-13
2020-06-30	$969,639,272	12,602,538	+14.4%	Shares	Defined	2020-08-24
2020-03-31	$823,840,170	11,019,799	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.